PALI
Palisade Bio Inc

19,613
Mkt Cap
$222.01M
Volume
6.55M
52W High
$2.64
52W Low
$0.53
PE Ratio
-0.35
PALI Fundamentals
Price
$1.49
Prev Close
$1.61
Open
$1.60
50D MA
$1.96
Beta
1.07
Avg. Volume
5.78M
EPS (Annual)
-$10.19
P/B
4.23
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Palisade Bio, Inc. (NASDAQ:PALI) Receives Average Rating of "Moderate Buy" from Brokerages
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are currently covering the stock, MarketBeat reports. One...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Short Interest Up 24.4% in December
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 15,949,282...
MarketBeat·12d ago
News Placeholder
Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold"
Wall Street Zen raised shares of Palisade Bio from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·29d ago
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com...
MarketBeat·1mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str
Clear Str raised shares of Palisade Bio to a "strong-buy" rating in a report on Monday...
MarketBeat·1mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler
Piper Sandler upgraded shares of Palisade Bio to a "strong-buy" rating in a report on Monday...
MarketBeat·1mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Palisade Bio from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know
Palisade Bio (PALI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·1mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Trading Up 0.6% - Here's What Happened
Palisade Bio (NASDAQ:PALI) Stock Price Up 0.6% - Should You Buy...
MarketBeat·2mo ago
News Placeholder
FY2025 EPS Estimate for Palisade Bio Increased by Analyst
Palisade Bio, Inc. (NASDAQ:PALI - Free Report) - Analysts at Brookline Capital Management upped their FY2025 earnings per share estimates for shares of Palisade Bio in a research note issued to...
MarketBeat·3mo ago
<
1
2
...
>

Latest PALI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.